These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23069229)

  • 41. [Multiple sebaceous hyperplasia secondary to ciclosporin in a heart transplant patient].
    Grillo E; Pérez-Gala S; Vano-Galván S; Jaén-Olasolo P
    Med Clin (Barc); 2013 Jul; 141(2):e3. PubMed ID: 23664109
    [No Abstract]   [Full Text] [Related]  

  • 42. Are direct oral anticoagulants such as edoxaban safer than heparin or vitamin K-antagonists when intracranial hemorrhage occurs?
    Dempfle CE
    Thromb Res; 2014 Apr; 133(4):521-2. PubMed ID: 24568776
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
    Pelosio L; Marasco A; Puopolo G
    Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
    [No Abstract]   [Full Text] [Related]  

  • 44. [Intracranial and intraspinal hemorrhage during anticoagulant therapy. Analysis of 52 cases].
    Desbordes JM; Deglaire B; Hulin A; Desplat A; Roualdes G
    Cah Anesthesiol; 1984 Mar; 32(3):209-12. PubMed ID: 6529657
    [No Abstract]   [Full Text] [Related]  

  • 45. Unscripted.
    Patel P; Dhaliwal G; Rajamanickam A; Gebresalassie S; Harte B
    J Hosp Med; 2010; 5(6):366-70. PubMed ID: 20803678
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical treatment of deep venous thrombosis].
    Maffei FH; Lastória S; Yoshida WB; Rollo HA
    AMB Rev Assoc Med Bras; 1984; 30(3-4):73-9. PubMed ID: 6382460
    [No Abstract]   [Full Text] [Related]  

  • 47. [Recurrent pyoderma gangrenosum-like ulcers induced by oral anticoagulants].
    Pralong P; Debarbieux S; Paret N; Balme B; Depaepe L; Nosbaum A; Ben-Said B; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2014 Jan; 141(1):34-8. PubMed ID: 24461092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hematochezia during anticoagulation. Pulmonary embolism as a life saver?].
    Stiefelhagen P
    MMW Fortschr Med; 2013 Dec; 155(21-22):30. PubMed ID: 24724260
    [No Abstract]   [Full Text] [Related]  

  • 49. [The adult intensive care physician and antivitamin K agents].
    Auzépy P; Rimailho A; Souied G; Riou B
    Agressologie; 1983 Nov; 24(11):549-54. PubMed ID: 6367510
    [No Abstract]   [Full Text] [Related]  

  • 50. Intramural hemorrhage of small intestine due to anticoagulants.
    Killian ST; Heitzman EJ
    JAMA; 1967 May; 200(7):591-4. PubMed ID: 5297869
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hemorrhagic complications of preventive anticoagulant therapy in surgery].
    Chapuis Y
    Helv Chir Acta; 1983 May; 50(1-2):173-86. PubMed ID: 6192109
    [No Abstract]   [Full Text] [Related]  

  • 52. Sirolimus-associated diffuse alveolar hemorrhage in a renal transplant recipient on long-term anticoagulation.
    Hashemi-Sadraei N; Sadrpour S; Baram D; Miller F; Nord EP
    Clin Nephrol; 2007 Oct; 68(4):238-44. PubMed ID: 17969492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe hemorrhagic syndrome due to similarity of drug names.
    Chiche L; Thomas G; Canavese S; Branger S; Jean R; Durand JM
    Eur J Intern Med; 2008 Mar; 19(2):135-6. PubMed ID: 18249310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 55. Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: An institutional experience.
    Hacker RI; Ritter G; Nelson C; Knobel D; Gupta R; Hopkins K; Marini CP; Barrera R
    J Crit Care; 2012 Jun; 27(3):250-4. PubMed ID: 22226424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.
    Ageno W; Garcia D; Aguilar MI; Douketis J; Finazzi G; Imberti D; Iorio A; Key NS; Lim W; Marietta M; Prisco D; Sarode R; Testa S; Tosetto A; Crowther M
    Am J Hematol; 2009 Sep; 84(9):584-8. PubMed ID: 19610020
    [No Abstract]   [Full Text] [Related]  

  • 57. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract]   [Full Text] [Related]  

  • 58. Solving the mystery of excessive warfarin-induced bleeding: a personal historical perspective.
    Hirsh J
    Thromb Haemost; 2014 Nov; 112(5):853-6. PubMed ID: 25300199
    [No Abstract]   [Full Text] [Related]  

  • 59. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.
    Morelon E; Stern M; Kreis H
    N Engl J Med; 2000 Jul; 343(3):225-6. PubMed ID: 10928875
    [No Abstract]   [Full Text] [Related]  

  • 60. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
    Shihab FS; Cibrik D; Chan L; Kim YS; Carmellini M; Walker R; Zibari G; Pattison J; Cornu-Artis C; Wang Z; Tedesco-Silva H
    Clin Transplant; 2013; 27(2):217-26. PubMed ID: 23230975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.